Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 13, 2013 - Issue 6
Submit an article Journal homepage
301
Views
17
CrossRef citations to date
0
Altmetric
Theme: Epilepsy - Review

AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel

Gaetano Zaccara Unit of Neurology, Department of Medicine, Florence Health Authority, Firenze, Italy. [email protected]; Unit of Neurology, Department of Medicine, Florence Health Authority, Firenze, Italy. [email protected]
,
Fabio Giovannelli Unit of Neurology, Department of Medicine, Florence Health Authority, Firenze, Italy; Unit of Neurology, Department of Medicine, Florence Health Authority, Firenze, Italy
,
Massimo Cincotta Unit of Neurology, Department of Medicine, Florence Health Authority, Firenze, Italy; Unit of Neurology, Department of Medicine, Florence Health Authority, Firenze, Italy
&
Alfonso Iudice Department of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy; Department of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy
Pages 647-655 | Published online: 09 Jan 2014

References

  • Kwan P, Brodie MJ. Emerging drugs for epilepsy. Expert Opin. Emerg. Drugs 12(3), 407–422 (2007).
  • Brodie MJ. Antiepileptic drug therapy the story so far. Seizure 19(10), 650–655 (2010).
  • Mula M. GABAergic drugs in the treatment of epilepsy: modern or outmoded? Future Med. Chem. 3(2), 177–182 (2011).
  • Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics 4(1), 18–61 (2007).
  • Landmark CJ. Targets for antiepileptic drugs in the synapse. Med. Sci. Monit. 13(1), RA1–RA7 (2007).
  • Watkins JC, Jane DE. The glutamate story. Br. J. Pharmacol. 147(Suppl. 1), S100–S108 (2006).
  • Kessels HW, Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron 61(3), 340–350 (2009).
  • Jane DE, Lodge D, Collingridge GL. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56(1), 90–113 (2009).
  • Cokic B, Stein V. Stargazin modulates AMPA receptor antagonism. Neuropharmacology 54(7), 1062–1070 (2008).
  • Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 11(2), 56–63 (2011).
  • Ghasemi M, Schachter SC. The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav. 22(4), 617–640 (2011).
  • De Sarro G, Gitto R, Russo E et al. AMPA receptor antagonists as potential anticonvulsant drugs. Curr. Top. Med. Chem. 5(1), 31–42 (2005).
  • Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 7(8), 742–755 (2008).
  • Hanada T, Hashizume Y, Tokuhara N et al. Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52(7), 1331–1340 (2011).
  • Langan YM, Lucas R, Jewell H et al. Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia 44(1), 46–53 (2003).
  • Howes JF, Bell C. Talampanel. Neurotherapeutics 4(1), 126–129 (2007).
  • Riva R, Albani F, Ambrosetto G et al. Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects. Epilepsia 25(4), 476–481 (1984).
  • Tothfalusi L, Speidl S, Endrenyi L. Exposure–response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets. Br. J. Clin. Pharmacol. 65(1), 110–122 (2008).
  • Löscher W, Schmidt D. Epilepsy: perampanel – new promise for refractory epilepsy? Nat. Rev. Neurol. 8(12), 661–662 (2012).
  • Fox SH, Brotchie JM, Lang AE. Non-dopaminergic treatments in development for Parkinson’s disease. Lancet Neurol. 7(10), 927–938 (2008).
  • Rascol O, Barone P, Behari M et al. Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone. Clin. Neuropharmacol. 35(1), 15–20 (2012).
  • Lees A, Fahn S, Eggert KM et al. Perampanel, an AMPA antagonist, found to have no benefit in reducing ‘off’ time in Parkinson’s disease. Mov. Disord. 27(2), 284–288 (2012).
  • Eggert K, Squillacote D, Barone P et al.; German Competence Network on Parkinson’s Disease. Safety and efficacy of perampanel in advanced Parkinson’s disease: a randomized, placebo-controlled study. Mov. Disord. 25(7), 896–905 (2010).
  • Konitsiotis S, Blanchet PJ, Verhagen L, Lamers E, Chase TN. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology 54(8), 1589–1595 (2000).
  • Marin C, Jiménez A, Bonastre M et al. LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats. Synapse 42(1), 40–47 (2001).
  • Krauss GL, Bar M, Biton V et al. Tolerability and safety of perampanel: two randomized dose-escalation studies. Acta Neurol. Scand. 125(1), 8–15 (2012).
  • French JA, Krauss GL, Biton V et al. Adjunctive perampanel for refractory partial-onset seizures: randomized Phase III study 304. Neurology 79(6), 589–596 (2012).
  • French JA, Krauss GL, Steinhoff BJ et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global Phase III study 305. Epilepsia 54(1), 117–125 (2013).
  • Krauss GL, Serratosa JM, Villanueva V et al. Randomized Phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 78(18), 1408–1415 (2012).
  • Rektor I, Krauss GL, Bar M et al. Perampanel Study 207: long-term open-label evaluation in patients with epilepsy. Acta Neurol. Scand. 126(4), 263–269 (2012).
  • Krauss GL, Perucca E, Ben-Menachem E et al. Perampanel, a selective, noncompetitive a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from Phase III, extension study 307. Epilepsia 54(1), 126–134 (2013).
  • Zaccara G, Cincotta M, Borgheresi A, Balestrieri F. Adverse motor effects induced by antiepileptic drugs. Epileptic Disord. 6(3), 153–168 (2004).
  • Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 48(7), 1223–1244 (2007).
  • Bannerman DM, Deacon RM, Brady S et al. Cognitive enhancing effects of an AMPA receptor positive modulator on place learning in mice. Behav. Brain Res. 226, 18–25 (2012).
  • Loring DW, Williamson DJ, Meador KJ, Wiegand F, Hulihan J. Topiramate dose effects on cognition: a randomized double-blind study. Neurology 76(2), 131–137 (2011).
  • Ben-Menachem E. Weight issues for people with epilepsy – a review. Epilepsia 48(Suppl. 9), 42–45 (2007).
  • Rektor I. Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures. Expert Opin. Pharmacother. 14(2), 225–235 (2013).
  • Rheims S, Ryvlin P. Retigabine for partial onset seizures. Expert Rev. Neurother. 12(5), 509–517 (2012).
  • Patsalos PN, Berry DJ. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate. Expert Opin. Pharmacother. 13(5), 699–715 (2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.